Victor Garcia, Ph.D. '15, has a demonstrated history of working in the higher education industry with emphasis in pharmacology, hypertension, receptor biology, vascular biology, and molecular biology.
Education
- Ph.D. '15, Pharmacology, New York Medical College
- Postdoctoral Fellowship, Pharmacology, Yale University
- M.S., Pharmacology, University of Medicine and Dentistry of New Jersey
- B.A., Biology, General, Drew University
Areas of Expertise
- Pharmacology
- Hypertension
- Receptor Biology
- Vascular Biology
- Molecular Biology
- Obesity
Research
Dr. Garcia’s lab is focused on the role of the vasoactive cytochrome P450 (CYP)-derived eicosanoid, 20-hydroxyeicosatetraenoic acid (20-HETE) and its recently identified high-affinity G-protein coupled receptor (GCR), GPR75. Understanding the 20-HETE/GPR75 pairing and how GPR75 mutations exhibit altered or disrupted receptor signaling will shed light as to how to better target GPR75, laying the necessary foundation for the development of novel receptor blockers that have the potential to treat diseases such as chronic kidney disease, hypertension, heart failure, and obesity; all of which are associated with elevations in 20-HETE.
Publications
- Zhu M, Diegisser D, Krasniqi D, Wolf A, Pascale J, Schwartzman M, Garcia V. 0027FATP1 Mediates Rapid 20-HETE/GPR75-Associated Fatty-Acid Uptake in Adipocytes: Implications for Cardiometabolic Disease. American Heart Journal. 2026 December; 302:107559-. doi: 10.1016/j.ahj.2026.107559.
- Podder D, Stala O, Miah A, Agyapong A, Moore M, Hirani R, Diegisser D, Garcia V, Etienne M. Incretin-Based Multi-Agonist Therapies for Type 2 Diabetes Mellitus and Obesity: Mechanisms, Clinical Efficacy, and Future Directions. Diabetology. 2026 March; 7(3):46-. doi: 10.3390/diabetology7030046.
- Hossain S, Villegas E, Liapes C, Sultana N, Krasniqi D, Diegisser D, Castro A, Williams C, Gruzdev A, Zeldin DC, Garcia V, Schwartzman ML. Gpr75 Deletion in Adipocytes Protects From Diet-Induced Obesity: Changes in Glucose Homeostasis and Inflammatory Responses. FASEB J. 2026 Feb 28;40(4):e71579. doi: 10.1096/fj.202504597R. PubMed PMID: 41707065; PubMed Central PMCID: PMC12916076.
- Hossain S, Villegas E, Liapes C, Sultana N, Krasniqi D, Diegisser D, Castro A, Williams C, Gruzdev A, Zeldin D, Garcia V, Schwartzman M. <i>Gpr75</i> Deletion in Adipocytes Protects From Diet‐Induced Obesity: Changes in Glucose Homeostasis and Inflammatory Responses. The FASEB Journal. 2026 February; 40(4):-. doi: 10.1096/fj.202504597R.
- Garcia V, Diegisser D, Wolf A, Pascale JV, Schwartzman ML. The evolving landscape of lipid mediator research: Emerging findings and observations from the 19th Winter Eicosanoid conference. Prostaglandins Other Lipid Mediat. 2026 Mar;183:107062. doi: 10.1016/j.prostaglandins.2026.107062. Epub 2026 Feb 12. PubMed PMID: 41690669.
- Gallagher J, Garcia V, Escaravage S, Gallagher P, Gallagher P, Diegisser D, Davalan W, Ben Ali W, Emmert M, Fusco D, Perrault L. Reply: Hydrodissection for conduit harvesting: Catch the wave!. JTCVS Open. 2026 February; 29:101567-. doi: 10.1016/j.xjon.2025.101567.
- Carnazza M, Yang N, Geliebter J, Tiwari R, Garcia V, Li XM. General commentary: 28-Day oral chronic toxicity study of arctigenin in rats. Front Pharmacol. 2025;16:1720821. doi: 10.3389/fphar.2025.1720821. eCollection 2025. PubMed PMID: 41657767; PubMed Central PMCID: PMC12879343.
Memberships and Affiliations
- American Physiological Society (APS)
- American Heart Association (AHA)
